Trial intelligence / Profile preview

Excretion of Fosfomycin Into Breast Milk Following ZTI-01 in Healthy Lactating Women

NCT07618299Phase 4Recruiting

Sponsor
Meitheal Pharmaceuticals
Start
Sep 2026
Primary completion
Sep 2027
Countries
1
01

Overview

A Phase 4 trial of fosfomycin in urinary tract infection (UTI), sponsored by Meitheal Pharmaceuticals. Started Sep 2026; status: recruiting.

02

Drugs

fosfomycin
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on NCT07618299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07618299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call